Comparative Antihyperglycaemic and Biochemical Effects of N-Hexane Extracts of Carica papaya and Laurus nobilis in Streptozotocin-Induced Diabetic Wistar Rats
Awurum Jennifer Chidera *
Department of Medical Biochemistry, Faculty of Basic Medical Sciences, Rivers State University, Port Harcourt, Nigeria.
K. A. Okari
Department of Medical Biochemistry, Faculty of Basic Medical Sciences, Rivers State University, Port Harcourt, Nigeria.
F. O. Robert
Department of Medical Biochemistry, Faculty of Basic Medical Sciences, Rivers State University, Port Harcourt, Nigeria.
C. Ijendu-Eletuo Virtue
Department of Medical Biochemistry, Faculty of Basic Medical Sciences, Rivers State University, Port Harcourt, Nigeria.
*Author to whom correspondence should be addressed.
Abstract
Background: Diabetes mellitus is characterised by persistent hyperglycaemia accompanied by dyslipidaemia, oxidative stress and injury to the liver, kidney and pancreas. Carica papaya (pawpaw) and Laurus nobilis (bay leaf) are traditionally used for glycaemic control, but the lipophilic, n-hexane-extractable constituents of their leaves have received little comparative attention. Objective: This study compared the effects of n-hexane leaf extracts of C. papaya and L. nobilis, given individually and in combination, on glycaemia, body weight, lipid profile, hepatic and renal indices, oxidative stress markers and liver and pancreatic histology in streptozotocin (STZ)-induced diabetic rats.
Methods: Thirty male Wistar rats (n = 5 per group) were assigned to normal control, untreated diabetic (negative control), metformin-treated (positive control), C. papaya-treated, L. nobilis-treated and combined-extract groups. Diabetes was induced with a single intraperitoneal dose of STZ (65 mg/kg) after one week of high-fat feeding. Extracts were prepared by Soxhlet extraction, profiled by gas chromatography–mass spectrometry (GC-MS) and administered orally at 200 mg/kg for 28 days.
Results: Untreated diabetic rats developed progressive hyperglycaemia (12.60 ± 0.32 to 16.10 ± 0.45 mmol/L), weight loss, dyslipidaemia, raised hepatic and renal indices and increased oxidative stress markers. At week 4, fasting blood glucose was 6.80 ± 0.28, 6.00 ± 0.16 and 5.45 ± 0.18 mmol/L in the C. papaya, L. nobilis and combined groups, respectively, compared with 6.25 ± 0.07 mmol/L with metformin. L. nobilis showed a more favourable single-extract profile relative to untreated diabetic rats: triglycerides were 1.42 ± 0.03 versus 4.72 ± 0.08 mmol/L, ALT 15.77 ± 0.73 versus 46.60 ± 0.96 U/L, creatinine 0.77 ± 0.02 versus 2.86 ± 0.07 mg/dL and malondialdehyde 5.64 ± 0.12 versus 18.59 ± 0.08 μmol/mg protein. The combined extract produced the greatest numerical normalisation, with several indices falling below normal-control values. Liver and pancreatic histology paralleled the biochemical findings.
Conclusion: Under the experimental conditions, n-hexane extracts of both plants, particularly L. nobilis, were associated with improved glycaemic, lipid, hepatic, renal and antioxidant indices. The combined extract was associated with the greatest improvement but also with values below those of healthy controls, suggesting that the combined dose may exceed the optimum, warranting dose-optimisation and safety studies.
Keywords: Carica papaya, laurus nobilis, n-hexane extract, diabetes mellitus, streptozotocin, wistar rats